Nucleai and Sirona Dx Partner to Deliver an Integrated Spatial Proteomics Solution for Pharma Drug Development Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a…
Quanterix Debuts Content Innovation Engine at AACR 2026 Quanterix Corporation today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration of Akoya Biosciences’ spatial biology platform…
Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming Pivotal Clinical Trial for FL115 (IL-15 Superagonist) in Nonmuscle Invasive Bladder Cancer (NMIBC) Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients…
Astellas Doses First Patient in Phase 3 Study of setidegrasib (ASP3082) for KRAS G12D-mutated Metastatic Pancreatic Ductal Adenocarcinoma Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the first patient has been successfully dosed in the Phase…
VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene…
Acumetis Launches as a Single Integrated Brand to Transform Life Sciences Commercialization Acumetis – a new global commercialization company for the life sciences industry – launches today. The company, formed as a combination of five well-known specialist consultancies – Herspiegel,…
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today highlighted Allogene Therapeutics’ (NASDAQ: ALLO) interim futility analysis from its registrational…
FairJourney Biologics Launches Cryo-EM Structural Biology Facility in San Diego FairJourney Bio (FJBio), a global contract research organization specializing in antibody discovery, has announced the opening of a cutting-edge cryo-electron microscopy (cryo-EM) structural biology facility in San Diego. The launch…
Bial Introduces Awareness and Education Initiative in Support of World Parkinson’s Day Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, has announced the launch of a major global awareness initiative titled “Dialogues with Parkinson’s” to mark World…
Vedanta Biosciences Highlights Advances in Microbiome-Based Therapeutics at ESCMID 2026 Global Congress Vedanta Biosciences, a late clinical-stage biopharmaceutical company focused on developing microbiome-based oral therapies for gastrointestinal diseases, has announced its participation in the upcoming European Society of Clinical Microbiology…
TAE Life Sciences Highlights Breakthrough BNCT Research Showing Sustained Tumor Control and Systemic Immune Effects TAE Life Sciences has announced the publication of new preclinical research in ACS Pharmacology & Translational Science, highlighting significant advancements in its next-generation boron delivery…
Aurion Biotech Initiates Dosing in Phase 3 ASTRA Study Evaluating AURN001 for Corneal Edema Secondary to Corneal Endothelial Dysfunction Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company focused on restoring vision and addressing corneal blindness, has announced…